Home/Filings/4/0001562180-20-001929
4//SEC Filing

Faulkingham Dell 4

Accession 0001562180-20-001929

CIK 0001517022other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 7:25 PM ET

Size

7.3 KB

Accession

0001562180-20-001929

Insider Transaction Report

Form 4
Period: 2020-02-28
Transactions
  • Award

    Common Stock

    2020-02-28+55,00080,000 total
  • Award

    Stock Option (Right to buy)

    2020-02-28+94,00094,000 total
    Exercise: $8.87Exp: 2030-02-28Common Stock (94,000 underlying)
Footnotes (2)
  • [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date.
  • [F2]The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.

Issuer

Akebia Therapeutics, Inc.

CIK 0001517022

Entity typeother

Related Parties

1
  • filerCIK 0001776024

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:25 PM ET
Size
7.3 KB